Pages
Products

Panoply™ Human DAO Knockdown Stable Cell Line

For research use only. Not intended for any clinical use.

Cat. No. :   CSC-DC004020

Host Cell :   HEK293 (Hela and other cell types are also available) Validation :   Real-Time RCR

Inquire for Price

Cell Line Information

Safety and Packaging

Gene Information

Cat. No. CSC-DC004020
Description Creative Biogene's Knockdown Cell Lines are target specific shRNA lentivirus transduced cells. The percent knockdown levels range from 75-99% depending on the gene, as evaluated by Real-Time RCR. Cells are rigorously qualified and mycoplasma free.
Target Gene DAO
Host Cell HEK293 (Hela and other cell types are also available)
Host Cell Species Homo sapiens (Human)
Applications

(1) Studying gene functions

(2) Studying gene interactions and signaling pathways

(3) Target validation and drug discovery

(4) Designing diseases models

Size >1 × 106 cells / vial
Stability Validated for at least 10 passages
Validation Real-Time RCR
Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Storage Liquid Nitrogen
Shipping Dry Ice
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations The following safety precautions should be observed.
1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.
2. No eating, drinking or smoking while handling the stable line.
3. Wash hands after handling the stable line and before leaving the lab.
4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.
5. All waste should be considered hazardous.
6. Dispose of all liquid waste after each experiment and treat with bleach.
Ship Dry ice
Gene Name DAO D-amino-acid oxidase [ Homo sapiens ]
Gene Symbol DAO
Synonyms DAO; D-amino-acid oxidase; DAMOX; D-amino acid oxidase; DAAO; OXDA; MGC35381;
Gene ID 1610
Uni Prot ID P14920
m RNA Refseq BC029057
Chromosome Location 12
Function D-amino-acid oxidase activity; D-amino-acid oxidase activity; FAD binding; nucleotide binding; oxidoreductase activity; protein binding; protein dimerization activity;
Pathway Arginine and proline metabolism, organism-specific biosystem; Arginine and proline metabolism, conserved biosystem; D-Arginine and D-ornithine metabolism, organism-specific biosystem; D-Arginine and D-ornithine metabolism, conserved biosystem; Glycine, serine and threonine metabolism, organism-specific biosystem; Glycine, serine and threonine metabolism, conserved biosystem; Glyoxylate metabolism, organism-specific biosystem;
MIM 124050
Quick Inquiry

Case Study

Q & A

Customer Reviews

D-amino acid oxidase (DAO) is a flavin adenine dinucleotide (FAD)-dependent oxidase that metabolizes neutral and polar D-amino acids. Unlike L-amino acids, D-amino acids are present in very low amounts in mammalian tissues, thus the physiological functions of DAO have been poorly studied. Recently, it has been found that DAO expression is upregulated during cellular senescence. Cellular senescence is a permanent cell cycle arrest induced by various stresses, such as persistent DNA damage and oxidative stress. Since DAO produces reactive oxygen species (ROS) as a byproduct during substrate oxidation, and the accumulation of ROS mediates the induction of cellular senescence, researchers have investigated the relationship between DAO and cellular senescence. They found that inhibiting DAO attenuates DNA damage-induced cellular senescence, while ectopic expression of wild-type DAO (rather than mutants lacking enzyme activity) enhances this senescence in a ROS-dependent manner. Furthermore, the addition of D-amino acids and riboflavin (a metabolic precursor of FAD) to the culture medium enhances the pro-senescence effect of DAO. These results indicate that DAO promotes cell senescence by enzymatically generating reactive oxygen species (ROS), and its activity is regulated by substrate and coenzyme availability.

To investigate whether DAO is involved in cellular senescence, researchers used two human tumor cell lines expressing wild-type p53-osteosarcoma U2OS cells and hepatocellular carcinoma HepG2 cells (Figure 1)-to assess the effect of DAO knockdown on DNA damage-induced cellular senescence. Researchers treated DAO-knockdown U2OS and HepG2 cells with the anticancer drug etoposide (a drug that induces DNA double-strand breaks), and then verified DAO expression levels using quantitative PCR (qPCR) and Western blot analysis (Figures 1A and 1B). They observed that in both U2OS and HepG2 cells, the proportion of SA-β-gal positive cells increased after etoposide treatment (Figures 1C and 1D), consistent with previous observations. More importantly, etoposide-induced SA-β-galactosidase activation was inhibited in DAO-knockdown cells. Furthermore, DAO knockdown partially restored the etoposide-induced loss of proliferation (Figure 1E). Immunoblotting analysis showed that DAO knockdown also inhibited the upregulation of p21, a key aging mediator induced by etoposide, although DAO knockdown may have caused only mild cellular stress, as p21 levels were slightly elevated even in the absence of etoposide (Figure 1F), suggesting that DAO may play a role in inducing aging.

Figure 1. Knockdown of DAO inhibits DNA damage-induced senescence.Figure 1. Knockdown of DAO inhibits DNA damage-induced senescence. (Nagano T, et al., 2019)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction